$LITS·4

MEI Pharma, Inc. · Jul 17, 1:24 PM ET

MEI Pharma, Inc. 4

4 · MEI Pharma, Inc. · Filed Jul 17, 2013

Insider Transaction Report

Form 4
Period: 2013-07-15
Mass Robert D.
Chief Medical Officer
Transactions
  • Award

    Option to purchase shares of common stock

    2013-07-15+34,000170,659 total
    Exercise: $7.43Exp: 2018-07-15Common Stock par value $0.00000002 (34,000 underlying)
Footnotes (2)
  • [F1]One-quarter of the options will vest on July 15, 2014; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months
  • [F2]The total number of derivative securities reported in column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012

Documents

1 file
  • 4
    c569602_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION